Publications found:
55,899
Sort by:
World Molecular Diagnostics Market 2017: Emerging Technologies and Strategic Profiles of Leading Suppliers
US$ 3,500.00
... report provides detailed analyses of current and emerging molecular diagnostic technologies, and their potential market applications, including DNA sequencing, RNA probes, detection ... strategic assessments of current and emerging suppliers of molecular diagnosticsproducts, including their sales, product portfolios, marketing tactics, technological know- how, new products ...
July 2017
180 pages
Spain Enteric Diseases Market Analysis and Emerging Opportunities 2021
US$ 2,200.00
... 322- page report from VPGMarketResearch.com presents detailed analysis of the Spanish Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter ... key suppliers and potential market entrants developing innovativetechnologies and products Analyzes emerging opportunities, alternative market penetration strategies,market entry barriers/risks ...
July 2017
322 pages
French Enteric Diseases Market Analysis and Emerging Opportunities 2021
US$ 2,200.00
... new 322- page report from VPGMarketResearch.com presents detailed analysis of the French Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter ... key suppliers and potential market entrants developing innovativetechnologies and products Analyzes emerging opportunities, alternative market penetration strategies,market entry barriers/risks ...
July 2017
322 pages
Europe Nucleic Acid Testing/NAT Market 2021: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 17,730.00
... , UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies ... range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend ...
June 2017
1273 pages
U.K. Nucleic Acid Testing/NAT Market 2021: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 6,030.00
... -page market segmentation analysis of the UK NAT market. Major issues pertaining to the UK NAT laboratory practice, as well as key economic, ... NAT instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing ...
June 2017
1122 pages
U.S. Nucleic Acid Testing/NAT Market 2021: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 8,550.00
... -page market segmentation analysis of the US NAT market. Major issues pertaining to the US NAT laboratory practice, as well as key economic, ... NAT instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing ...
June 2017
1157 pages
France Nucleic Acid Testing/NAT Market 2021: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 6,030.00
... 1,125-page market segmentation analysis of the French NAT market. Major issues pertaining to the French NAT laboratory practice, as well as ... NAT instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing ...
June 2017
1125 pages
Germany Nucleic Acid Testing/NAT Market 2021: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 6,030.00
... 1,125-page market segmentation analysis of the German NAT market. Major issues pertaining to the German NAT laboratory practice, as well as ... NAT instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing ...
June 2017
1125 pages
Japan Nucleic Acid Testing/NAT Market 2021: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 7,650.00
... 126-page market segmentation analysis of the Japanese NAT market. Major issues pertaining to the Japanese NAT laboratory practice, as well as ... NAT instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing ...
June 2017
1126 pages
Spain Nucleic Acid Testing/NAT Market 2021: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 6,030.00
... 1,117-page market segmentation analysis of the Spanish NAT market. Major issues pertaining to the Spanish NAT laboratory practice, as well as ... NAT instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing ...
June 2017
1117 pages
Italy Nucleic Acid Testing/NAT Market 2021: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 6,030.00
... 1,117-page market segmentation analysis of the Italian NAT market. Major issues pertaining to the Italian NAT laboratory practice, as well as ... NAT instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing ...
June 2017
1117 pages
US Hospital Tumor Marker Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 5,850.00
... 567 pages, 50 tables, and presents a comprehensive analysis of the US hospital tumor market testing market, including: Major issues pertaining to the US laboratory practice, as well ... , ovarian, testicular, oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in US hospitals. Current instrumentation technologies and feature comparison ...
June 2017
567 pages
UK Hospital Tumor Marker Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 3,465.00
... , 37 tables, and presents a comprehensive analysis of the UK hospital tumor marker testing market, including: Major issues pertaining to the UK hospital laboratory practice, as well as key economic, regulatory ... , ovarian, testicular, oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in UK hospitals. Current instrumentation technologies and feature comparison ...
June 2017
527 pages
French Hospital Infectious Disease Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 4,005.00
... , 77 tables, and presents a comprehensive analysis of the French hospital infectious disease testing market, including: Major issues pertaining to the French hospital laboratory practice, as well as key economic, regulatory ... on definition, epidemiology, and etiology of major infectious diseases and microorganisms. Volume and sales forecasts for 80 infectious disease tests performed in French hospital laboratories. Instrumentation technologies and feature ...
June 2017
897 pages
German Hospital Infectious Disease Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 4,005.00
... , 74 tables, and presents a comprehensive analysis of the German hospital infectious disease testing market, including: Major issues pertaining to the German hospital laboratory practice, as well as key economic, regulatory ... on definition, epidemiology, and etiology of major infectious diseases and microorganisms. Volume and sales forecasts for 80 infectious disease tests performed in German hospital laboratories. Instrumentation technologies and feature ...
June 2017
897 pages
Italian Hospital Infectious Disease Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 4,005.00
... , 72 tables, and presents a comprehensive analysis of the Italian hospital infectious disease testing market, including: Major issues pertaining to the Italian hospital laboratory practice, as well as key economic, regulatory ... on definition, epidemiology, and etiology of major infectious diseases and microorganisms. Volume and sales forecasts for 80 infectious disease tests performed in Italian hospital laboratories. Instrumentation technologies and feature ...
June 2017
887 pages
Japanese Hospital Infectious Disease Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 5,220.00
... , 75 tables, and presents a comprehensive analysis of the Japanese hospital infectious disease testing market, including: Major issues pertaining to the Japanese hospital laboratory practice, as well as key economic, regulatory ... on definition, epidemiology, and etiology of major infectious diseases and microorganisms. Volume and sales forecasts for 80 infectious disease tests performed in Japanese hospital laboratories. Instrumentation technologies and feature ...
June 2017
891 pages
Spanish Hospital Infectious Disease Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 4,005.00
... , 73 tables, and presents a comprehensive analysis of the Spanish hospital infectious disease testing market, including: Major issues pertaining to the Spanish hospital laboratory practice, as well as key economic, regulatory ... on definition, epidemiology, and etiology of major infectious diseases and microorganisms. Volume and sales forecasts for 80 infectious disease tests performed in Spanish hospital laboratories. Instrumentation technologies and feature ...
June 2017
880 pages
French Hospital Tumor Marker Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 3,465.00
... , 43 tables, and presents a comprehensive analysis of the French hospital tumor marker testing market, including: Major issues pertaining to the French hospital laboratory practice, as well as key economic, regulatory ... , ovarian, testicular, oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in French hospitals. Current instrumentation technologies and feature comparison ...
June 2017
533 pages
German Hospital Tumor Marker Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 3,465.00
... , 40 tables, and presents a comprehensive analysis of the German hospital tumor marker testing market, including: Major issues pertaining to the German hospital laboratory practice, as well as key economic, regulatory ... , ovarian, testicular, oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in German hospitals. Current instrumentation technologies and feature comparison ...
June 2017
530 pages
Italian Hospital Tumor Marker Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 3,465.00
... , 38 tables, and presents a comprehensive analysis of the Italian hospital tumor marker testing market, including: Major issues pertaining to the Italian hospital laboratory practice, as well as key economic, regulatory ... , ovarian, testicular, oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in Italian hospitals. Current instrumentation technologies and feature comparison ...
June 2017
525 pages
Japanese Hospital Tumor Marker Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 4,365.00
... , 42 tables, and presents a comprehensive analysis of the Japanese hospital tumor marker testing market, including: Major issues pertaining to the Japanese hospital laboratory practice, as well as key economic, regulatory ... , ovarian, testicular, oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in Japanese hospitals. Current instrumentation technologies and feature comparison ...
June 2017
537 pages
Spanish Hospital Tumor Marker Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 3,465.00
... , 41 tables, and presents a comprehensive analysis of the Spanish hospital tumor marker testing market, including: Major issues pertaining to the Spanish hospital laboratory practice, as well as key economic, regulatory ... , ovarian, testicular, oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in Spanish hospitals. Current instrumentation technologies and feature comparison ...
June 2017
521 pages
Australia Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
Austria Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
Belgium Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
Bulgaria Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
Canada Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
Cyprus Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
Czech Republic Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... . Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, ... risks. Cancer Diagnostic Tests Analyzed in the Report--over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...
June 2017
535 pages
Denmark Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
Estonia Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
Finland Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
